Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.10187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Huaxian Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Department of Coloproctology), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Prov…. Hauptthemen laut MEDLINE: Saponins, Constipation, Triterpenes, Single-Cell Analysis. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The cellular characteristics of intestinal cells involved in the therapeutic effects of astragaloside IV (AS-IV) for treating slow transit constipation (STC) remain unclear. This study aimed to determine the dynamics of colon tissue cells in the STC model and investigate the effects of AS-IV treatment by single-cell RNA sequencing (scRNA-seq). STC mouse models were developed using loperamide, with subsequent treatment using AS-IV. Colon tissues and feces were collected for scRNA-seq and targeted short-chain fatty acid quantification. We integrated scRNA-seq data with network pharmacology to analyze the effect of AS-IV on constipation. AS-IV showed improvement in defecation for STC mice induced by loperamide. Notably, in STC mice, epithelial cells, T cells, B cells, and fibroblasts demonstrated alterations in cell proportions and aberrant functions, which AS-IV partially rectified. AS-IV has the potential to modulate the metabolic pathway of epithelial cells through its interaction with peroxisome proliferator-activated receptor gamma (PPARγ). AS-IV reinstated fecal butyrate levels and improved energy metabolism in epithelial cells. The proportion of naïve CD4+T cells is elevated in STC, and the differentiation of these cells into regulatory T cells (Treg) is regulated by B cells and fibroblasts through the interaction of ligand-receptor pairs. AS-IV treatment can partially alleviate this trend. The status of fibroblasts in STC undergoes alterations, and the FB_C4_Adamdec1 subset, associated with angiogenesis and the Wingless-related integration (Wnt) pathway, emerges. Our comprehensive analysis identifies perturbations of epithelial cells and tissue microenvironment cells in STC and elucidates mechanisms underlying the therapeutic efficacy of AS-IV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery (Department of Coloproctology), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Six…
- Department of Anaesthesiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Chen, H., Wan, X., He, Q., Xiao, G., Zheng, Y., Luo, M., Yang, C., Ren, D., Lu, L., Peng, H., & Lin, H. (2024). Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10187
Vancouver
Chen H, Wan X, He Q, Xiao G, Zheng Y, Luo M, et al. Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10187
BibTeX
@article{Chen2024,
author = {Chen, Huaxian and Wan, Xingyang and He, Qiulan and Xiao, Guozhong and Zheng, Yihui and Luo, Minyi and Yang, Chaoxin and Ren, Donglin and Lu, Li and Peng, Hui and Lin, Hongcheng},
title = {Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.10187}
}
EUVIMED